AFX Endovascular AAA System BA25-80/I13-40Recalls & reported problems
Endologix LLC · Class 3 · Implant
All models of AFX Endovascular AAA System (48)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 8
- Deaths reported
- 0
- Injuries reported
- 8
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00818009010179), received between Jul 6, 2016 and Aug 29, 2023 — classified as 8 injuries.
The most frequently reported specific device problem is “Leak/Splash” (3 reports).
16 other recalls cover devices cleared under the same FDA submission (P040002); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Leak/Splash3
- Hole In Material2
- Insufficient Device Problem Information2
- Loss of or Failure to Bond2
- Material Integrity Problem2
- Deformation Due to Compressive Stress1
- Lack of Effect1
- Material Puncture/Hole1
Patient problems
- Failure of Implant7
- Stenosis2
- Abdominal Pain1
- Aneurysm1
- Clinical Endoleak1
- Pain1
- Rupture1
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
InjuryAug 29, 2023Insufficient Device Problem Information; Lack of Effect; Insufficient Device Problem Information; Lack of Effect
THE PATIENT WAS INITIALLY IMPLANTED WITH AN AFX BIFURCATED STENT GRAFT AND A VELA SUPRARENAL STENT GRAFT TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY FIVE (5) YEARS POST-INITIAL IMPLANT AND DURING ROUTINE FOLLOW-UP, THE CT (COMPUTED TOMOGRAPHY) SCAN IDENTIFIED CAUDAL MIGRATION OF THE PROXIMAL AFX GRAFT MEASURING GREATER THAN 10MM. REFERENCE MFR. REPORT # 2031527-2021-00195. APPROXIMATELY SEVEN (7) YEARS POST-INITIAL IMPLANTATION, A FOLLOW-UP PROCEDURE CONDUCTED WITH THE PATIENT REVEALED THE EMERGENCE OF AN EXPANDING ANEURYSM. IN LIGHT OF THIS OBSERVATION, THE ATTENDING PHYSICIAN IS CONTEMPLATING THE IMPLANTATION OF AN EXTENSION. THE PATIENT'S CURRENT STATUS IS REPORTED AS DOING WELL.
Patient problems: Aneurysm; Clinical Endoleak
MAUDE report 17643599 ↗InjuryJun 4, 2019Misconnection; Deformation Due to Compressive Stress; Misconnection; Deformation Due to Compressive Stress
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE AFX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY 4.5 YEARS POST INITIAL PROCEDURE, THE PATIENT PRESENTED EMERGENTLY WITH ABDOMINAL PAIN. CT SCAN REVEALED A TYPE IIIA ENDOLEAK WITH COMPONENT SEPARATION BETWEEN THE BIFURCATED AND PROXIMAL EXTENSION DEVICES. HOWEVER, THE EXACT DATE OF EVENT IS NOT CONFIRMED. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY IMPLANTING TWO (2) ADDITIONAL SUPRARENAL AFX DEVICES ON (B)(6) 2019, AND THE ENDOLEAK WAS CONFIRMED SUCCESSFULLY REPAIRED AT THE CONCLUSION OF THE PROCEDURE. THE PATIENT DID WELL DURING THE PROCEDURE AND WAS REPORTEDLY STABLE. THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant; Pain; Rupture; Stenosis
MAUDE report 8668420 ↗InjuryMar 18, 2019Material Puncture/Hole; Product Quality Problem; Use of Device Problem; Material Integrity Problem; Material Puncture/Hole; Product Quality Problem; Use of Device Problem; Material Integrity Problem
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE AFX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY FOUR (4) YEARS POST INITIAL PROCEDURE, A TYPE IIIB ENDOLEAK WAS DETECTED BY CT DURING ROUTINE FOLLOW-UP. THE PHYSICIAN WILL CONTINUE TO MONITOR THE PATIENT WHO IS REPORTEDLY IN GOOD CONDITION. THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant
MAUDE report 8429815 ↗InjuryFeb 8, 2019Loss of or Failure to Bond; Insufficient Device Problem Information; Loss of or Failure to Bond; Insufficient Device Problem Information
ADDITIONAL INFORMATION RECEIVED CONFIRMING THAT THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY RELINING WITH AN ADDITIONAL SUPRARENAL AND ONE (1) INFRARENAL AFX DEVICES ON (B)(6) 2019.
Patient problems: Failure of Implant
MAUDE report 8321449 ↗InjuryFeb 7, 2019Loss of or Failure to Bond; Loss of or Failure to Bond
Patient problems: Failure of Implant
MAUDE report 8316656 ↗InjuryJan 5, 2018Hole In Material; Leak/Splash; Material Integrity Problem; Hole In Material; Leak/Splash; Material Integrity Problem
ON (B)(6) 2015, THE PATIENT WAS INITIALLY IMPLANTED WITH A BIFURCATED STENT AND A SUPRARENAL EXTENSION. ON (B)(6) 2017, ENDOLOGIX WAS MADE AWARE OF A TYPE 3B ENDOLEAK. THE PHYSICIAN ELECTED TO RELINE THE INITIAL DEVICE WITH OVATION DEVICES TO RESOLVE THIS LEAK. THE PATIENT WAS REPORTED IN STABLE CONDITION AND THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant; Stenosis
MAUDE report 7167414 ↗InjuryNov 1, 2017Leak/Splash; Leak/Splash
AN AFX BIFURCATED STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE PATIENT RETURNED FOR A FOLLOW-UP WHERE PHYSICIAN OBSERVED A POTENTIAL ENDOLEAK THROUGH ANGIOGRAPHIC REVIEW. A RE-INTERVENTION IS SCHEDULED AT A LATER DATE WHERE PHYSICIAN WILL PERFORM A FULL RELINE USING AN AFX2 BIFURCATED DEVICE. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant
MAUDE report 6994835 ↗InjuryJul 6, 2016Hole In Material; Leak/Splash; Hole In Material; Leak/Splash
PATIENT INITIALLY IMPLANTED WITH A BIFURCATED STENT AND A SUPRARENAL AORTIC EXTENSION ON (B)(6) 2014. ON (B)(6) 2016 THE PATIENT CAME IN EMERGENTLY WITH ABDOMINAL PAIN AND COMPUTED TOMOGRAPHY (CT) SHOWED A POTENTIAL TYPE 3B ENDOLEAK. THE PHYSICIAN ELECTED TO IMPLANT A NON-ENDOLOGIX STENT TO SEAL THE LEAK. THE PATIENT WAS IN STABLE CONDITION POST PROCEDURE.
Patient problems: Abdominal Pain; Failure of Implant
MAUDE report 5774157 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P040002. One submission often covers many models, so check the product and lot details in each record.
- Z-1049-2017 · Jan 4, 2017 · TerminatedAFX2 Endovascular AAA System Item No. Item Description F00820-01 BEA28-120/I20-40 F00820-02 BEA28-100/I20-40 F00820-03 BEA28-80/I20-40 F00820-06 BEA28-120/I16-40 F00820-07 B
- Z-1048-2017 · Jan 4, 2017 · TerminatedAFX Endovascular AAA System Item Number Item Description F0070305 A2525/C75 V F0070308 A2828/C75 V F0070312 A3434/C
- Z-1038-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIB; The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (A
- Z-1037-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1039-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type: IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1047-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA Product Usage: The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoili
- Z-1035-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA
- Z-1054-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-0592-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-140BL
- Z-0589-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-140BL
- Z-0591-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-135BL
- Z-0594-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-135BL
- Z-0595-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-140BL
- Z-0590-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-155BL
- Z-0596-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-155BL
…and 1 more.
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page